PMID- 28714339 OWN - NLM STAT- MEDLINE DCOM- 20181025 LR - 20181025 IS - 1476-4954 (Electronic) IS - 1476-4954 (Linking) VI - 31 IP - 20 DP - 2018 Oct TI - Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. PG - 2665-2672 LID - 10.1080/14767058.2017.1350644 [doi] AB - OBJECTIVES: To compare death and/or neurodevelopmental outcomes of preterm infants exposed to inhaled and/or systemic steroids with those without exposure, and examine the impact of timing of exposure. METHODS: Retrospective study of infants born <29 weeks gestation and assessed at 18-21 months corrected age (CA). Neurodevelopmental impairment (NDI) was defined as any Bayley Scales of Infant and Toddler Development-III (BSID-III) score <85, cerebral palsy >/= grade one, and visual or hearing impairment. Significant NDI (sNDI) was defined as any Bayley Scales of Infant Development (BSID-III) score <70, cerebral palsy >/= grade three, or severe vision or hearing impairment. RESULTS: Of 2570 neonates, 1811 had no exposure, 125 were exposed to inhaled steroids, 522 to systemic steroids and 112 to both. Infants exposed to inhaled steroids had lower odds of bronchopulmonary dysplasia [adjusted odds ratio (AOR) 0.51, (0.33, 0.79)], and displayed no difference in death/NDI or death/significant neurodevelopmental impairment (sNDI), regardless of timing of exposure. Infants only exposed to systemic steroids before 4 weeks of age were at increased odds of death/NDI [AOR 1.83 (1.43, 2.34)] and death/sNDI [AOR 2.28 (1.76, 2.96)]. CONCLUSIONS: Exposure to inhaled steroids was not associated with increased odds of death/NDI or death/sNDI. Systemic steroids use before 4 weeks of age was associated with significantly worse outcomes. FAU - Kelly, Edmond N AU - Kelly EN AD - a Department of Paediatrics , Mount Sinai Hospital , Toronto , Canada. AD - b Department of Paediatrics , University of Toronto , Toronto , Canada. FAU - Shah, Vibhuti S AU - Shah VS AD - a Department of Paediatrics , Mount Sinai Hospital , Toronto , Canada. AD - b Department of Paediatrics , University of Toronto , Toronto , Canada. FAU - Levenbach, Jody AU - Levenbach J AD - a Department of Paediatrics , Mount Sinai Hospital , Toronto , Canada. FAU - Vincer, Michael AU - Vincer M AD - c Department of Paediatrics , IWK Health Centre , Halifax , Canada. FAU - DaSilva, Orlando AU - DaSilva O AD - d Department of Paediatrics , Western University , London , Canada. FAU - Shah, Prakesh S AU - Shah PS AD - a Department of Paediatrics , Mount Sinai Hospital , Toronto , Canada. AD - b Department of Paediatrics , University of Toronto , Toronto , Canada. CN - Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators LA - eng PT - Journal Article DEP - 20170716 PL - England TA - J Matern Fetal Neonatal Med JT - The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians JID - 101136916 RN - 0 (Adrenal Cortex Hormones) SB - IM MH - Administration, Inhalation MH - Adrenal Cortex Hormones/*administration & dosage/*adverse effects MH - Bronchopulmonary Dysplasia/*drug therapy/mortality MH - Canada/epidemiology MH - Female MH - Humans MH - Infant MH - Infant, Newborn MH - Infant, Premature MH - Male MH - Neurodevelopmental Disorders/*chemically induced MH - Retrospective Studies OTO - NOTNLM OT - Bronchopulmonary dysplasia OT - mortality OT - neonates OT - neurodevelopmental outcomes OT - prematurity OT - steroids EDAT- 2017/07/18 06:00 MHDA- 2018/10/26 06:00 CRDT- 2017/07/18 06:00 PHST- 2017/07/18 06:00 [pubmed] PHST- 2018/10/26 06:00 [medline] PHST- 2017/07/18 06:00 [entrez] AID - 10.1080/14767058.2017.1350644 [doi] PST - ppublish SO - J Matern Fetal Neonatal Med. 2018 Oct;31(20):2665-2672. doi: 10.1080/14767058.2017.1350644. Epub 2017 Jul 16.